Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
Not Applicable
- Conditions
- Autoimmune PancreatitisIgG4-related Sclerosing CholangitisObstructive Jaundice
- Interventions
- Drug: corticosteroidsProcedure: biliary stent
- Registration Number
- NCT02797665
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- adults greater than 18 years-old;
- autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;
- obstructive jaundice
Exclusion Criteria
- malignancies; active infections;
- pregnancy or breast feeding;
- standard contraindications to ERCP;
- unwillingness or inability to consent for the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Stent group corticosteroids The patients will be treated with oral corticosteroids and biliary stent. Stent group biliary stent The patients will be treated with oral corticosteroids and biliary stent. Steroids group corticosteroids The patients will be treated with oral corticosteroids (prednisone 0.6mg/kg/d) alone.
- Primary Outcome Measures
Name Time Method Clinical remission rate of obstructive jaundice Day 60
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking Union Medical College Hospital
🇨🇳Beijing, Beijing, China